Through market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports provide more actionable and strategically valuable research.
Sexually Transmitted Diseases (STD) Testing Market Size Outlook: How Fast Will Revenue Grow Through 2030?
The market for sexually transmitted disease (STD) testing has experienced considerable expansion recently, projected to increase from $8.78 billion in 2025 to $9.52 billion in 2026, reflecting a compound annual growth rate (CAGR) of 8.5%. This historical growth trajectory has been influenced by several key factors, including heightened awareness surrounding sexual health, the amplification of public health screening initiatives, advancements in laboratory diagnostic technologies, a burgeoning incidence of sexually transmitted infections, and the broadened accessibility of testing services.
The global market for sexually transmitted disease (STD) testing is poised for significant expansion over the upcoming years, projected to reach a valuation of $13.05 billion by 2030. This remarkable growth is anticipated to occur at a compound annual growth rate (CAGR) of 8.2%. Several key factors are fueling this upward trajectory, including a greater need for discreet testing options, a surge in financial backing for molecular diagnostic advancements, the broader implementation of testing facilitated by telehealth services, a heightened emphasis on proactive health management, and the proactive implementation of governmental programs aimed at disease containment. During this same forecast period, notable trends expected to shape the market include a greater acceptance of at-home STD testing kits, increased utilization of sophisticated molecular diagnostic techniques, the growing incorporation of digital health platforms into testing protocols, the wider availability of rapid point-of-care testing solutions, and an intensified focus on identifying and addressing diseases in their earliest stages.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24695&type=smp
Sexually Transmitted Diseases (STD) Testing Market Growth Drivers: What Factors Are Accelerating Expansion?
The increasing incidence of HIV is expected to be a significant driver for the expansion of the sexually transmitted diseases (STD) testing market in the foreseeable future. HIV, a pathogen that compromises the body’s defenses by targeting and eliminating essential white blood cells, leaves individuals susceptible to various ailments. This escalation in HIV diagnoses can be attributed to diminished awareness and reduced preventative measures, leading to an increase in high-risk activities like unprotected sexual contact and a decrease in testing rates, particularly among younger demographics. Consequently, the surge in HIV infections bolsters the need for STD testing by amplifying public and medical attention, motivating a greater number of individuals to undergo thorough screening for early detection and to curb onward transmission. As an illustration, data from UNAIDS, a governmental consortium headquartered in Switzerland, revealed in July 2024 that approximately 1.3 million new HIV infections occurred in 2023, a figure nearly threefold the 2025 objective of fewer than 370,000 cases, underscoring the substantial growth potential for the STD testing market due to the escalating HIV rates.
Sexually Transmitted Diseases (STD) Testing Market Segmentation Trends And Revenue Drivers
The sexually transmitted diseases (std) testing market covered in this report is segmented –
1) By Product: Instruments And Services, Consumables, Software
2) By Technology: Immunoassay, Molecular Diagnostics
3) By Sample Type: Blood Samples, Urine Samples, Swabs, Semen Samples, Other Sample Types
4) By Disease Type: Chlamydia, Gonorrhea, Syphilis, HIV Or AIDS, Herpes Simplex Virus (HSV)
5) By End User: Individuals, Healthcare Providers, Diagnostic Laboratories, Govement Health Agencies, NGOs And Community Health Organizations
Subsegments:
1) By Instruments And Services: Diagnostic Instruments, Testing Services
2) By Consumables: Reagents And Kits, Specimen Collection Devices, Slides, Tubes
3) By Software: Laboratory Information Management Systems (LIMS), Electronic Health Records (EHR) Integration Tools, Data Analysis And Reporting Tools, Patient Management Software
Sexually Transmitted Diseases (STD) Testing Market Trends: What Is Shaping Future Industry Growth?
Leading entities within the sexually transmitted diseases (STD) testing sector are emphasizing the creation of sophisticated diagnostic options, including syphilis testing kits, with the aim of broadening public access to testing services. These syphilis testing kits are instruments designed to identify the Treponema pallidum bacterium, the causative agent of syphilis, by analyzing blood or other bodily fluids to facilitate prompt diagnosis and intervention. As an illustration, in August of 2023, iHealth Labs Inc., a medical device manufacturer based in the United States, introduced the CheckMeSafe home collection kit, offering testing for both HIV and syphilis. This FDA-authorized iHealth CheckMeSafe Home Collection kit empowers individuals aged eighteen and above to gather blood samples for HIV (screening for I, II, and P24 antigen) and syphilis testing conveniently and privately at home. The collected samples can be dispatched to the laboratory via a pre-paid overnight shipping label, with confidential and dependable results becoming available in approximately two days. The kit delivers exceptionally precise outcomes, achieving sensitivity levels of up to 99.9% for HIV and 99.5% for syphilis. Sample analysis is conducted in a CLIA-certified and CAP-accredited laboratory, guaranteeing adherence to stringent federal and state quality mandates through consistent oversight.
Sexually Transmitted Diseases (STD) Testing Market Industry Leaders: Which Organizations Are Driving Competition?
Major companies operating in the sexually transmitted diseases (std) testing market are F Hoffmann La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Siemens Healthineers AG, Becton Dickinson And Co., Hologic Inc., QuidelOrtho Corp., Bio-Rad Laboratories Inc., Cepheid, OraSure Technologies Inc., Meridian Bioscience Inc., Sekisui Diagnostics Ltd., Trinity Biotech Plc, Chembio Diagnostics Inc., Operon SA, Jal Medical Pte. Ltd., Anatolia Geneworks, CLIAwaived Inc., Avecon Healthcare Pvt. Ltd., AEHEALTH LIMITED.
Access The Complete Sexually Transmitted Diseases (STD) Testing Market Report:
Sexually Transmitted Diseases (STD) Testing Market Regional Distribution: Which Areas Drive Market Expansion?
North Americawas the largest region in the sexually transmitted diseases (STD) testing market in 2025. Europeis expected to be the fastest-growing region in the forecast period. The regions covered in the sexually transmitted diseases (std) testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
